DIC Syndrome Calculator

What Is the DIC Syndrome Calculator?

This calculator estimates the likelihood of disseminated intravascular coagulation (DIC) using a standardized scoring system based on routine clinical and laboratory findings. It applies the International Society on Thrombosis and Haemostasis (ISTH) overt DIC diagnostic criteria to help clinicians assess whether a patient's presentation is consistent with DIC.

The tool is intended for use in patients with an underlying condition known to be associated with DIC, such as sepsis, trauma, malignancy, or obstetric complications. It does not diagnose DIC independently but provides a structured framework for risk stratification.

How the Scoring System Works

The ISTH overt DIC score is calculated from five laboratory parameters. Each parameter is assigned a score based on the degree of abnormality. The total score determines the likelihood of overt DIC.

A total score of 5 or higher is consistent with overt DIC. A score below 5 suggests that overt DIC is less likely, though the condition may still be evolving or non-overt.

How to Use the Calculator

1. Enter the patient's platelet count in the designated field.
2. Select the D-dimer or fibrin degradation product result (no increase, moderate increase, or strong increase).
3. Enter the prothrombin time (PT) prolongation in seconds above the normal reference range.
4. Enter the fibrinogen level in g/L.
5. The calculator will compute the total ISTH score and display the corresponding DIC likelihood.

All lab values should be from the same blood draw to ensure consistency. The tool assumes standard laboratory reference ranges; adjust interpretation if your lab uses non-standard thresholds.

Interpreting the Results

The output provides a numerical score and a categorical assessment. A score of 5 or more indicates overt DIC, meaning the coagulation system is actively consuming clotting factors and platelets, leading to both thrombosis and bleeding. This warrants immediate clinical attention and supportive management.

A score below 5 does not rule out DIC entirely. Patients with non-overt DIC or early-stage DIC may score lower. Serial scoring over time can capture disease progression or resolution.

The calculator does not account for clinical context such as bleeding severity, organ dysfunction, or the specific underlying condition. These factors remain essential for clinical decision-making.

Common Mistakes When Using the DIC Score

• Using the score without an appropriate clinical context. The ISTH criteria are validated only for patients with a known condition associated with DIC. Applying them to an unselected population reduces specificity.
• Misinterpreting a moderate D-dimer increase. The scoring system distinguishes between moderate and strong increases. Using the wrong category changes the total score significantly.
• Ignoring the PT prolongation unit. The score uses seconds above the normal reference, not the INR or raw PT value. Ensure you enter the prolongation, not the absolute value.
• Assuming a low score excludes DIC. A score of 3 or 4 does not rule out evolving DIC. Repeat testing within 24–48 hours is often warranted.

Limitations of the Calculator

• The ISTH overt DIC score has moderate sensitivity and specificity. It is a supportive tool, not a definitive diagnostic test.
• Inter-laboratory variability in D-dimer assays and PT reagents can affect scoring consistency.
• The score does not account for fibrinogen consumption in patients with very low baseline fibrinogen or in those receiving anticoagulants.
• Pediatric and obstetric populations may have different baseline coagulation profiles; the standard ISTH criteria may not apply directly.
• The calculator provides a single time-point assessment. DIC is a dynamic process, and serial evaluation is often more informative.

Practical Use Cases

• Emergency department triage: Rapidly assess a septic patient with thrombocytopenia and prolonged coagulation times to determine the need for hematology consultation.
• ICU monitoring: Track DIC scores daily in critically ill patients to identify worsening coagulopathy or response to treatment.
• Obstetric assessment: Evaluate a patient with placental abruption or amniotic fluid embolism for concurrent DIC.
• Malignancy workup: Screen for DIC in a patient with acute promyelocytic leukemia or advanced solid tumors presenting with bleeding.